Abstract
Early-life stress is correlated with the development of anxiety-related behavior in adolescence, but underlying mechanisms remain poorly known. The α1A-adrenergic receptor (AR) is linked to mood regulation and its function is assumed to be regulated by β-arrestins (βArrs) via desensitization and downregulation. Here, we investigated correlation between changes in α1A-AR and βArr2 levels in the prefrontal cortex (PFC) and hippocampus of adolescent and adult male rats subjected to maternal separation (MS) and their relationship with anxiety-like behavior in adolescence. MS was performed 3 h per day from postnatal days 2–11 and anxiety-like behavior was evaluated in the elevated plus-maze and open field tests. The protein levels were examined using western blot assay. MS decreased α1A-AR expression and increased βArr2 expression in both brain regions of adolescent rats, while induced reverse changes in adulthood. MS adolescent rats demonstrated higher anxiety-type behavior and lower activity in behavioral tests than controls. Decreased α1A-AR levels in MS adolescence strongly correlated with reduced time spent in the open field central area, consistent with increased anxiety-like behavior. An anxiety-like phenotype was mimicked by acute and chronic treatment of developing rats with prazosin, an α1A-AR antagonist, suggesting α1A-AR downregulation may facilitate anxiety behavior in MS adolescent rats. Together, our results indicate a negative correlation between α1A-AR neurotransmission and βArr2 levels in both adults and anxious-adolescent rats and suggest that increased βArr2 levels may contribute to posttranslational regulation of α1A-AR and modulation of anxiety-like behavior in adolescent rats. This may provide a path to develop more effective anxiolytic treatments.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
There is a growing body of evidence demonstrating that early life stress can increase the risk of developing future psychopathologies, including mood and anxiety disorders (Johnson et al. 2002; Heim et al. 2004; Varese et al. 2012; Vaiserman 2015). Several human and animal studies suggest that early exposure to stressors causes structural and functional alterations in brain areas involved in emotional behavior (Vythilingam et al. 2002; Teicher et al. 2006; Krugers and Joels 2014; Soares-Cunha et al. 2018). For example, early-life adversity was associated with a reduction in the volume of the prefrontal cortex (PFC) (van Harmelen et al. 2010) and the hippocampus (Rao et al. 2010; Teicher et al. 2012), greater activation of the hypothalamic–pituitary–adrenal axis (Danese and McEwen 2012) and impairment of synaptic plasticity (Herpfer et al. 2012; Chocyk et al. 2013; Bondar and Merkulova 2016; Janthakhin et al. 2017; Rincel et al. 2018). Although mechanisms underlying the consequences of early-life stress are not well-understood, several lines of evidence suggest that susceptibility to stress-induced psychopathology may in part be due to brain noradrenergic dysregulation (Sullivan et al. 1999; Ressler and Nemeroff 2000; Goddard et al. 2010).
Adrenergic receptors (ARs) are a class of G-protein–coupled receptors (GPCRs) and are classified as α1, α2, and β. The α1‐ARs are the most abundant ARs in the brain, but their role is the least understood. The α1-ARs have three subtypes (α1A, α1B, α1D) and mediate multiple physiological impacts of norepinephrine. In rat brain, low levels of the ARs present at birth and reach maximum levels during the first 3 weeks after birth (Morris et al. 1980; Murrin et al. 2007). Stress exposure during this critical period of development has been shown to delay or impair the normal development of (ARs). For example, early-life stress resulted in a delayed development of ARs in cerebral cortex of infant offspring and decreased α2-AR binding in several brain regions in adult offspring rats (Peters 1984) as well as in the lateral septum of teleost fish (Vindas et al. 2018). Early-life stress has also been shown to reduce α1B-AR binding sites in the cingulate cortex and hippocampus and increase α1A and α1B-AR in the hippocampus of adult mice (Coccurello et al. 2014). Furthermore, early-life stress was found to disturb maternal-infant attachment learning, a type of early learning which is important in shaping behavior in adult (Fillion and Blass. 1986; Sevelinges et al. 2007, 2011; Raineki et al. 2010), in part via an effect on noradrenergic system (Moriceau et al. 2009).
A role of α1-ARs in mood regulation has been reported in previous studies. For example, the α1A-AR stimulation was found to improve cognitive function, while α1B-AR activation impaired learning and memory (Philipp and Hein 2004). In addition, transgenic mice expressing a constitutively active mutant form of α1A-AR exhibited an antidepressant-like phenotype that was reversed by prazosin, a α1-AR antagonist (Sevelinges et al. 2007). It has also been shown that antidepressant action of electroconvulsive shock is associated with an increase in the receptor density and mRNA levels of α1A-AR in the rat cerebral cortex and hippocampus (Fillion and Blass 1986). Both α1A-ARs and α1B-AR are expressed in several brain areas involved in the modulation of anxiety-like behavior including the PFC, amygdala, hippocampus, and paraventricular nuclei of the hypothalamus (Nalepa et al. 2002, 2013; Papay et al. 2006). Neurogenesis has been shown to decrease anxiety and depression-related behaviors in a mouse model of stress (Hill et al. 2015). While activation of the α1A-AR has been shown to promote neurogenesis, α1B-AR leads to neurodegeneration (Piascik and Perez 2001). Another study indicated that long-term α1A-AR stimulation leads to decreased depression- and anxiety-like behavior in mice (Doze et al. 2009). Furthermore, tricylic antidepressants, which have been shown to be effective in treating a wide variety of anxiety disorders (Zohar and Westenberg 2000), enhance the α1-ARs density in the forebrain, hippocampus, and cerebral cortex of rodents (Rehavi et al. 1980; Deupree et al. 2007), suggesting upregulation of α1-AR expression may be involved in the anxiolytic effect of tricylic antidepressants. α1-AR antagonist has also been demonstrated to decrease anxiety-related symptoms in patients with post-traumatic stress disorder (Peskind et al. 2003; Raskind et al. 2003). Together, these data suggest a possible role for α1A-AR in anxiety-like behavior.
A major mechanism that controls the responsiveness of GPCRs is homologous desensitization. GPCRs can be desensitized by phosphorylation of the agonist-activated receptor by G-protein-coupled receptor kinase 2. The phosphorylated receptors are then bound by β-arrestins (βArrs), and this interaction in turn blocks further activation of G proteins and downstream signaling pathways and causes receptor internalization (Benovic et al. 1987; Lohse et al. 1990; Oakley et al. 2000, 2001; Laporte et al. 2002; Krasel et al. 2005; Tian et al. 2014; Jean-Charles et al. 2017). Internalized receptors can be recycled to the cell surface (resensitization) or downregulated via degradation in lysosomes (Gainetdinov et al. 2004). Similar to other GPCRs, the α1A-ARs undergo homologous desensitization and internalization following adrenergic agonist stimulation (Hennenberg et al. 2011; Nalepa et al. 2013), which in turn can affect the density of the α1A-ARs and alter their function. There is a growing body of evidence that indicates a role of βArr isoforms in mood regulation. For example, in mice exposed to the HIV-1 transactivator of transcription protein, βArr2 caused μ-opioid-receptor desensitization in amygdala and was associated with enhanced fear and anxiety in the animals (Hahn et al. 2016). Moreover, mice lacking βArr1 or 2 are viable and healthy, but they exhibit altered physiology and behavior compared to wild-type mice (Bjork et al. 2008; Zurkovsky et al. 2017). Previous studies have also indicated that the 17 δ-opioid receptor (δOR; a GPCR) selective agonist SNC80, which has anxiolytic (Saitoh et al. 2004, 2018) and fear-decreasing effects (Saitoh et al. 2004; Li et al. 2009), recruits βArr 1 and 2 (Chiang et al. 2016; Pradhan et al. 2016; Vicente-Sanchez et al. 2018), while the δOR-selective agonist TAN67, which is a weak βArr 2 recruiter, was not associated with a reduction in anxiety-like behavior in mice (van Rijn et al. 2010), suggesting a possible role of βArr2 in anxiety behavior. In addition, mitogen activated protein kinases, which have been shown to be involved in mood regulation, can scaffold with βArr (Coyle and Duman 2003; Lefkowitz and Shenoy 2005).
In the present study, we attempted to characterize the effects of early-life stress, such as maternal separation (MS), on changes in the expression of the α1-AR and βArr2 in the PFC and hippocampus of adolescent and adult male rats, and to see if there are correlations between changes in the α1-AR and βArr2 levels and anxiety-like behavior in developing brain.
Experimental procedure
Pregnant females were housed 4–5 per cage until gestational day 17 and then, were housed in individual cages. The day of birth was considered as day 0. Litters were randomly assigned to one of the two experimental states on day 2: MS (N = 8) and unhandled (control, N = 8). MS carried out between postnatal days (PNDs) 2 and 11, a sensitive period for maternal-infant attachment learning, which is important in shaping behavior in adult (Fillion and Blass 1986; Raineki et al. 2010; Sevelinges et al. 2011). Pups were separated from the dam and transferred in a new cage to a different room (to prevent communication with the dam) for 3 h per day (during the light phase, beginning at 8 am) and then were returned to the dam and the home cage. Dams were removed from home cages to a clean cage with ad libitum food and water during MS. During the experiment, the cage was placed on a hot plate set at a temperature of 35 °C, to avoid cooling of rat pups. Litters were weaned at PND 21 and male rats separated from their female littermates. Male pups were group-housed four to five per cage, and food and water were available ad libitum. Rats were housed under controlled environmental states with lights on at 7:00 and controlled temperature and humidity of the room. The behavioral tests were performed in 35–36-day-old male rats (adolescent period). Rats of each group in adolescent rats, after finishing the last behavioral tests, and in adult rats, at PND 62 were killed for western blotting analysis. All procedures were performed in accordance with the National Institutes of animal care and use guidelines approved by the Institutional Ethic Committee (IEC) at Urmia University of Medical Sciences (IR.UMSU.REC.1397.288).
Behavioral tests
At 35–36 day of age, the rat offspring underwent two behavioral tests for anxiety-like behaviors, including elevated plus-maze (EPM) test and open field (OF) test. Behavioral testing was performed in the morning by the investigator blind to the experimental condition under a room light. All test sessions were recorded via a vertically video camera and monitored from an adjacent laboratory.
The OF provides a method for evaluating novel environment exploration, total locomotor activity and anxiety-related behaviors in rodents (Prut and Belzung 2003). To evaluate locomotor activity and anxiety-like behavior, rats were placed individually into a standard OF activity test chamber and were left to explore for 10 min in an arena (40 cm × 40 cm × 35 cm). In the present study, time spent within the central area (16 × 16 cm2) of the OF as well as the percentage of distance traveled in the center (calculated by (distance traveled in center/distance traveled in periphery + distance traveled in center) × 100) were measured as indicators of anxiety-like behavior. Total distance traveled in the OF (automatically recorded) , a measure of general locomotor activity, is also interpreted as an anxiety-like response (Sestakova et al. 2013). The chamber was carefully cleaned with ethanol solution after each test and dried between each rat in accordance with previous studies (Seibenhener and Wooten 2015).
The EPM was comprised of two closed arms enclosed by 30 cm high walls (30 × 5 × 5 cm) and two open arms with no walls (30 × 5 × 0.25 cm). Rats were individually placed on the central platform of the EPM facing an open arm in a 5-min test period. The entrance to a maze arm was defined if the rat places all four paws onto the arm. Rats were evaluated for time spent in the open arm and the number of entries into open arm as a measure of anxiety-like behavior. The number of open arm entries was calculated as the percentage of entries in the open arms = number of open arm entries/(number of open arm entries + number of closed arm entries) × 100. The time spent in the open arm was also evaluated as the percentage of time spent in open arms = time spent in the open arms/(time spent in open arms + time spent in the closed arms) × 100.
Western blot
To examine alterations in α1A-AR and βArr2 protein levels in the hippocampus and PFC between groups, adolescent (PND 36; after the behavioral tests) and adult (PND 62) male rats (N = 8 for each group) were used for western blot analysis. The animals were sacrificed by cervical dislocation, then the hippocampus and the PFC tissues were removed. The tissues were homogenized in ice-cold lysis buffer containing 50 mmol/L Tris, pH 8.0, 150 mmol/L NaCl, 1 mmol/L EGTA, 50 mmol/L NaF, 1.5 mmol/L MgCl2, 10% v/v glycerol, 1% v/v Triton X‐100, 1 mmol/L phenylmethylsulfonyl fluoride, 1 mmol/L Na3VO4, and Complete Protease Inhibitor cocktail (Roche Diagnostics, Indianapolis, IN, USA). After centrifugation at 12,000 cycle/min for 10 min, the protein levels in the supernatants were determined and equal amounts of proteins were then loaded onto a 10% polyacrylamide gel. After electrophoresis, the gels were transferred to polyvinylidene difluoride membranes. The membranes were blocked with 5% skim milk prepared in Tris-buffered saline with Tween (TBST) and incubated with primary antibodies α1A-AR (Santa Cruz Biotechnology, Inc.), βArr2 (Santa Cruz Biotechnology, Inc.) and β-actin (Sigma-Aldrich) at 4 °C, overnight, and subsequently with the appropriate HRP-conjugated secondary antibodies for 1 h at room temperature and then visualized via enhanced chemiluminescence detection on the X-ray films. The result of the western blotting was scanned, and densitometric analysis for the quantification of the bands was done using Image J software (National Institutes of Health, Bethesda, MD, USA). Anti βarr2 and anti α1A-AR were probed on the same gel. The α1A-AR and βArr2 levels were normalized with that of β-actin, used for internal control protein.
Prazosin treatment
For α1A-AR blockade, prazosin hydrochloride (Sigma) was intraperitoneally administered to adolescent rats at dosages of 0.2 and 1 mg/kg, 30 min before anxiety behavioral tests. In chronic injections, the same doses of prazosin were used for 5 consecutive days from PND 31 to PND 35. Rats were then tested at PND 35–36 for anxiety-like behavioral tests. Normal saline was administered to each control group. The doses of prazosin were chosen based on previous studies (Doze et al. 2009; Do-Monte et al. 2010; Funk et al. 2019).
Statistical analysis
Statistical analysis was performed using GraphPad Prism (GraphPad Software, San Diego, CA). Comparisons between two and three groups were analyzed by unpaired student’s t test and one-way analysis of variance (ANOVA) followed by Tukey’s post-hoc test, respectively. In addition, differences within groups were analyzed by paired student’s t test. Repeated measures ANOVA was used to determine the effect of MS on rat protein levels over time. The Pearson correlation coefficient was conducted to assess the correlation between animals’ behavioral test performance and the protein expression in the PFC and hippocampus. All values are mean ± S.E.M. p < 0.05 was considered significant.
Results
Maternal separation induces anxiety-like behavior in adolescent rats
Increased anxiety in the EPM is related to a less preference for open arms. MS adolescent rats exhibited a significant reduction in time spent in the open arms (p = 0.0036) compared to controls (Fig. 1a), reflecting less time exploring open arms at stress group. We also found a significant decrease in the percentage of entries into open arm of stress group (p = 0.0450) compared to control group (Fig. 1b). These results suggest that MS increases anxiety-like behavior in adolescent rats. (N = 8 for each group).
Anxiety-like behaviors in the OF are related to reduced general locomotor activity and decreased time spent and distance traveled in the central area. In the present study, adolescent rats in stress group exhibited a significant decrease in time spent (p = 0.0043) and in the percentage of distance traveled (p = 0.0013) in the OF central area compared to control group (Fig. 1c, d). We also measured total distance traveled in the entire OF (as a measure of locomotor activity) and observed a significant reduction in stress group (p = 0.013) compared to controls (Fig. 1e). (N = 8 for each group).
Maternal separation differentially affects α1A-AR and βArr2 expression in adolescent and adult male rats
The results of western blot revealed a significant decrease in α1A-AR expression and a significant increase in βArr2 levels in both the hippocampus (for α1A-AR: p < 0.0001, Fig. 2a; for βArr2: p = 0.0005, Fig. 2b) and PFC (for α1A-AR: p = 0.0086, Fig. 3a; for βArr2: p = 0.0001, Fig. 3b) of MS adolescent rats compared to controls. (N = 8 for each group).
Repeated MS also led to changes in the α1A-AR and βArr2 expression as measured in the hippocampus and PFC of 62-day-old rats. In contrast to adolescence, MS resulted in a significant increase in α1A-AR expression (p = 0.0213) in the hippocampus of MS adult rats compared to controls (Fig. 2c), while changes in the hippocampal βArr2 levels were not significant (p = 0.389) (Fig. 2d). In the PFC of adult male rats subjected to MS, there was lower expression of α1A-AR (p = 0.0379) and greater expression of βArr2 (p = 0.0012) than controls (Fig. 3c, d). These differences in the α1A-AR and βArr2 expression between adolescent and adult male rats suggest that MS differentially influences α1A-AR and βArr2 levels during adolescence and adulthood. (N = 8 for each group).
The comparison of developmental effects of MS on the protein levels indicated that changes in the expression of α1A-AR and βArr2 of MS adolescent rats were reversed in MS adult rats, with a significant increase in the expression of α1A-AR and a marked decrease in βArr2 expression in both the hippocampus (for α1A-AR: p = 0.0001, Fig. 2e; for βArr2: p = 0.0012, Fig. 2f) and PFC (for α1A-AR: p = 0.0467, Fig. 3e; for βArr2: p = 0.0264, Fig. 3f) of MS adult rats compared with MS adolescence. (N = 8 for each group).
Anxiety-like behavior is inversely correlated with α1A-AR expression
As shown in Fig. 4, there is a positive association between time spent in the OF central area (as inverse index of anxiety-like behavior) with α1A-AR levels in both hippocampus (control group: r = 0.80, p = 0.0159; stress group: r = 0.90, p < 0.01; Fig. 4a) and PFC (control group: r = 0.83, p < 0.01; stress group: r = 0.90, p < 0.01; Fig. 4b).
Acute and chronic treatment with prazosin significantly increased anxiety-like behaviors in adolescent male rats
Since an anxiety-like phenotype in MS adolescent rats was associated with α1A-ARs downregulation, we hypothesized that this behavior could be mimicked by treating developing rats with an α1A-AR antagonist. We used prazosin, an α1A-AR antagonist (Doze et al. 2009), to determine whether the anxiety-like phenotype could be induced in adolescent rats by blocking α1A-AR. Intraperitoneal injection of prazosin at dosages of 0.2 mg/kg and 1 mg/kg (Doze et al. 2009; Do-Monte et al. 2010; Funk et al. 2019), was performed 30 min prior to anxiety behavioral tests. We also investigated the effects of chronic prazosin treatment of developing rats on anxiety-like behaviors in adolescent rats. Prazosin at dosages of 0.2 mg/kg and 1 mg/kg was administered to rats for 5 consecutive days from PND 31 to PND 35. Rats were then tested for anxiety behavioral tests at PND 35–36.
In the OF, a single acute injection of prazosin at dosages of 0.2 and 1 mg/kg during PND 35 resulted in a significant less time spent [F(2,18) = 9.556, p = 0.0015; Fig. 5a] and lower distance traveled [F(2,17) = 18.83, p < 0.0001; Fig. 5b] in the center in adolescent rats than controls, suggesting a higher level of anxiety in acute prazosin group than control group. Similar results were obtained with chronic administration of prazosin (at dosages of 0.2 and 1 mg/kg) [for time spent in the center: F(2,18) = 7.511, p = 0.0042, Fig. 5d; for distance traveled in the center: F(2,17) = 6.122, p = 0.0099, Fig. 5e]. Furthermore, adolescent rats in both acute [F(2,17) = 17.29, p < 0.0001] and chronic [F(2,18) = 11.68, p = 0.0006] groups displayed hypoactivity, shown by reduced total distance traveled in the OF compared to controls, consistent with an increase in anxiety levels (Fig. 5c, f).
In the EPM, adolescent rats with acute and chronic injection of prazosin spent less time in open arm [for acute prazosin injection: F(2,18) = 16.79, p < 0.0001, Fig. 5g; for chronic prazosin injection: F(2,18) = 5.648, p = 0.0125, Fig. 5i] and had lower number of open arm entries [for acute prazosin injection: F(2,18) = 7.858, p = 0.0035, Fig. 5h; for chronic prazosin injection: F(2,17) = 5.175, p = 0.0176, Fig. 5j] than controls. (N = 7 for each group).
Taken together, these data provide further evidence that MS-induced anxiety-like behavior in adolescent rats may in part be due to decreased α1A-AR signaling.
Discussion
Early-life stress is known to interfere with brain development and maturation, increasing later risk for a variety of psychiatric disorders, including anxiety disorders, in part via perturbing the programming of the limbic system including hippocampus and prefrontal cortex, two essential mediators of early-life stress on subsequent behavior later in life (Teicher et al. 2003; Champagne et al. 2008; Lupien et al. 2009; Kim et al. 2015; Arnsten et al. 2015). Adolescence is a crucial period of development that is vulnerable to the onset of specific mental health problems (Kessler et al. 2012). Since βArrs are assumed to be involved in the regulation of GPCRs including ARs, hence, this study was conducted to examine few consequences of repeated early-life stress by evaluating the effects of early MS on changes in α1A-AR and βArr2 expression in the PFC and hippocampus of adolescent and adult male rats. We also investigated the presence of a possible relationship between the protein levels and anxiety behavior in adolescent male rats as well as the effect of reducing α1A-AR neurotransmission during development on anxiety-like responses in adolescent animals.
Assessment of anxiety behavior of adolescent rats in the EPM revealed a higher level of anxiety in stress group, shown by lower percentage of time spent in the open arm and open arm entries. The OF data indicated decreased time spent and distance traveled in the center (as indicators of anxiety-like behavior) in MS adolescent rats, which indicates more anxiety than control rats. In addition, the percentage of total distance traveled in the center (as an indicator of locomotor activity) was decreased in MS adolescent rats. In our study, developing brain also responded to repeated MS by downregulating α1A-ARs in the PFC and hippocampus. This MS-induced decrease in α1A-AR expression in the hippocampus and PFC of adolescent rats was reversed in adult rats, with a significant increase in the α1A-AR levels in both brain regions, suggesting that MS differentially influences α1A-AR expression during adolescence and adulthood. Previous research has shown conflicting results for the effect of early-life stress on anxiety as well as on α1-AR expression in developing and mature brain, likely in part due to different stress protocols used. For example, prenatal stress was found to cause a reduction in α1-AR binding in cerebral cortex of rats at 16 but not at 23, 40 or 60 days of age (Peters 1984). In another study, MS (from days 1–13) produced enduring downregulation of α1-ARs in the prefrontal-limbic forebrain/limbic midbrain network in adult mice (Coccurello et al. 2014). Regarding the effects of MS on anxiety behavior, Jin et al. reported that MS (3 h from PND1-21) produced a significant decrease in locomotor activity and increased anxiety-like behaviors in adolescent rats (Jin et al. 2018), while MS for 4 h per day from PND1-21 resulted in enhanced locomotor activity and reduced anxiety behavior of adolescent rats in the OF (Qiong et al. 2015).
Novelty-seeking has been shown to affect anxiety-like behavior in the OF (Prut and Belzung 2003), and exploratory behavior in response to novelty appears to be largely mediated via activation of noradrenergic system (Sara et al. 1995; Rebec et al. 1997; Stone et al. 1999, 2006, 2011; Collier et al. 2004). Mc Fie et al. indicated that clozapine, which has a strong α1-AR antagonistic effect, reduces exploratory activity and increases anxiety-like behavior in Wistar-Kyoto rats at PND 35–36 (Mc Fie et al. 2012). This is consistent with our findings that revealed that a decreased level of α1A-AR in MS adolescent rats strongly correlates with an increase in anxiety-like behavior in the animals. Other studies have also demonstrated that α1-AR antagonists reduce locomotor activity in several rodent models of hyperactivity (Velley et al. 1982; Snoddy and Tessel 1985; Blanc et al. 2002), supported by the studies that demonstrated Wistar-Kyoto rats, which have hypofunctionality of noradrenergic neurotransmission (Howells and Russell 2008; Howells et al. 2012), are hypoactive compared to other species rats (Gentsch et al. 1987; Pare 1994; Ferguson and Cada 2003). These data and the result obtained from our study suggest a role of α1A-AR in exploratory behavior in response to novelty.
Downregulation of α1-ARs is a mechanism of AR deactivation (Finch et al. 2006) and occurs via receptor internalization, enhanced degradation via endosomal-lysosomal system, or decreased the reporter mRNA expression (Lefkowitz 1998). βArrs could interact to α1-ARs and potentially cause functional alterations (Uberti et al. 2003). In the present study, in contrast to α1A-AR, MS resulted in increased expression of βArr2 in the PFC and hippocampus of adolescent rats, suggesting the existence of a mechanism of adrenergic deactivation likely in response to stress-induced increased βArr2 levels. However, it has been unclear whether downregulation of α1A-AR expression during development may be involved in modulation of anxiety-like behaviors in adolescent rats. In the present study, we indicated that acute and chronic pharmacological blockade of α1A-AR with prazosin, a α1A-AR antagonist, resulted in increased anxiety-like behavior and decreased activity in adolescent rats, suggesting that MS-induced anxiety-like behavior in adolescent rats may in part due to decreased α1A-AR signaling. In our study, MS-induced increase in βArr2 expression in the hippocampus and PFC of adolescent rats was reversed in adult rats. This in turn may affect BArr2 in adolescent and adult rats. βArrs have been linked to anxiety regulation (Asth et al. 2016; Ding et al. 2017; Robins et al. 2018). For example, mice lacking βArr1 in mice decreased anxiety in both sexes (Robins et al. 2018). Furthermore, nociceptin/orphanin FQ (N/OFQ) receptor agonists can cause anxiolytic-like effect in rodents and this effect has been shown to be determined by βArr2 recruitment (Asth et al. 2016). These data suggest that developing and mature brains are differentially regulated by βArr2.
Differences observed in the α1A-AR expression and βArr2 (as a possible regulator of α1A-AR expression) in developing and adult brain following repeated MS exposure may have long-term effects on α1A-AR function, as shown for α2-AR. For example, a differential response of the developing and mature brain to norepinephrine regulation of α2-AR density has been demonstrated in previous research (Sanders et al. 2011), and has been suggested to be in part responsible for the therapeutic effects of tricyclic antidepressants in adult depression and the lack of their efficacy in the treatment of childhood depression (Deupree et al. 2007; Bylund and Reed 2007; Sanders et al. 2011).
Together, our findings suggest a possible interaction of βarr2 with α1A-AR in the PFC and hippocampus of adolescent rats. Early-life stress increase in βArr2 levels may promote this interaction and decrease α1A-AR neurotransmission via downregulating the receptors, which in turn could facilitate anxiety-like behavior. Hence, targeting βArr2 may provide a new opportunity for developing more effective anxiolytic treatments.
Abbreviations
- PFC:
-
Prefrontal cortex
- AR:
-
Adrenergic receptor
- GPCR:
-
G protein-coupled receptor
- MS:
-
Maternal separation
- βArr:
-
β-Arrestin
- EPM:
-
Elevated plus-maze
- OF:
-
Open field
- PZ:
-
Prazosin
References
Arnsten AF, Raskind MA, Taylor FB, Connor DF (2015) The effects of stress exposure on prefrontal cortex: translating basic research into successful treatments for post-traumatic stress disorder. Neurobiol Stress 1:89–99
Asth L, Ruzza C, Malfacini D, Medeiros I, Guerrini R, Zaveri NT, Gavioli EC, Calo G (2016) Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic-versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands. Neuropharmacology 105:434–442
Benovic JL, Kühn H, Weyand I, Codina J, Caron MG, Lefkowitz RJ (1987) Functional desensitization of the isolated beta-adrenergic receptor by the beta-adrenergic receptor kinase: potential role of an analog of the retinal protein arrestin (48-kDa protein). Proc Natl Acad Sci U S A 84:8879–8882
Bjork K, Rimondini R, Hansson AC, Terasmaa A, Hyytia P, Heilig M, Sommer WH (2008) Modulation of voluntary ethanol consumption by beta-arrestin 2. FASEB J 22:2552–2560
Blanc R, Ville A, Glowinski J, Tassin J (2002) Critical role of a1-adrenergic receptors in acute and sensitized locomotor effects of D-amphetamine, cocaine, and GBR12783: influence of preexposure conditions and pharmacological characteristics. Synapse 43:51–61
Bondar NP, Merkulova TI (2016) Brain-derived neurotrophic factor and early-life stress: multifaceted interplay. J Biosci 41:751–758
Bylund DB, Reed AL (2007) Childhood and adolescent depression: why do children and adults respond differently to antidepressant drugs? Neurochem Int 51:246–253
Champagne DL, Bagot RC, van Hasselt F, Ramakers G, Meaney MJ, de Kloet ER, Joëls M, Krugers H (2008) Maternal care and hippocampal plasticity: evidence for experience-dependent structural plasticity, altered synaptic functioning, and differential responsiveness to glucocorticoids and stress. J Neurosci 28:6037–6045
Chiang T, Sansuk K, van Rijn RM (2016) beta-Arrestin 2 dependence of delta opioid receptor agonists is correlated with alcohol intake. Br J Pharmacol 173:332–343
Chocyk A, Bobula B, Dudys D, Przyborowska A, Majcher-Maślanka I, Hess G, Wędzony K (2013) Early-life stress affects the structural and functional plasticity of the medial prefrontal cortex in adolescent rats. Eur J Neurosci 38:2089–2107
Coccurello R, Bielawski A, Zelek-Molik A, Vetulani J, Kowalska M, D’Amato FR, Nalepa I (2014) Brief maternal separation affects brain α1-adrenoceptors and apoptotic signaling in adult mice. Prog Neuropsychopharmacol Biol Psychiatry 48:161–169
Collier TJ, Greene JG, Felten DL, Stevens SY, Steece K (2004) Reduced cortical noradrenergic neurotransmission is associated with increased neophobia and impaired spatial memory in aged rats. Neurobiol Aging 25:209–221
Coyle JT, Duman RS (2003) Finding the intracellular signaling pathways affected by mood disorder treatments. Neuron 38:157–160
Danese A, McEwen BS (2012) Adverse childhood experiences, allostasis, allostatic load, and age-related disease. Physiol Behav 106:29–39
Deupree JD, Reed AL, Bylund DB (2007) Differential effects of the tricyclic antidepressant desipramine on the density of adrenergic receptors in juvenile and adult rats. J Pharmacol Exp Ther 321(2):770–776
Ding J, Han F, Wen L, Xiao B, Shi Y (2017) The role of β-arrestin-2 on Fear/anxious-related memory in a rat model of Post-traumatic stress disorder. J Affect Disord 213:1–8
Do-Monte FHM, Melody Allensworth M, Carobrez AP (2010) Impairment of contextual conditioned fear extinction after microinjection of alpha-1-adrenergic blocker prazosin into the medial prefrontal cortex. Behav Brain Res 211:89–95
Doze VA, Handel EM, Jensen KA, Darsie B, Luger EJ, Haselton JR, Talbot JN, Rorabaugh BR (2009) a1A- and a1B adrenergic receptors differentially modulate antidepressant-like behavior in the mouse. Brain Res 1285:148–157
Ferguson SA, Cada AM (2003) A longitudinal study of short- and long-term activity levels in male and female spontaneously hypertensive, Wistar-Kyoto and Sprague-Dawley rats. Behav Neurosci 117:271–282
Fillion T, Blass E (1986) Infantile experience with suckling odors determines adult sexual behavior in male rats. Science 231:729–731
Finch AM, Sarramegna V, Graham RM (2006) Ligand Binding, Activation, and Agonist Trafficking. In: Perez DM (ed) The Adrenergic Receptors. The Receptors. Humana Press
Funk D, Coen K, Tamadon S, Le AD (2019) Effects of the alpha-1 antagonist prazosin on KOR agonist-induced reinstatement of alcohol seeking. Int J Neuropsychopharmacol 22:724–734
Gainetdinov RR, Premont RT, Bohn LM, Lefkowitz RJ, Caron MG (2004) Desensitization of G protein-coupled receptors and neuronal functions. Annu Rev Neurosci 27:107–144
Gentsch C, Lichtsteiner M, Feer H (1987) Open field and elevated plus-maze: a between, open field and elevated plus-maze: a behavioural comparison between spontaneously hypertensive (SHR) and Wistar-Kyoto (WKY) rats and the effects of chlordiazepoxide. Behav Brain Res 25:101–107
Goddard AW, Ball SG, Martinez J, Robinson MJ, Yang CR, Russell JM, Shekhar A (2010) Current perspectives of the roles of the central norepinephrine system in anxiety and depression. Depress Anxiety 27:339–350
Hahn YK, Paris JJ, Lichtman AH, Hauser KF, Sim-Selley LJ, Selley DE, Selley DE, Knapp PE (2016) Central HIV-1 Tat exposure elevates anxiety and fear conditioned responses of male mice concurrent with altered mu-opioid receptor-mediated G-protein activation and β-arrestin 2 activity in the forebrain. Neurobiol Dis 92:124–136
Heim C, Plotsky PM, Nemeroff CB (2004) Importance of studying the contributions of early adverse experience to neurobiological findings in depression. Neuropsychopharmacology 29:641–648
Hennenberg M, Schlenker B, Roosen A, Strittmatter F, Walther S, Stief C, Gratzke C (2011) β-arrestin-2 is expressed in human prostate smooth muscle and a binding partner of α1A-adrenoceptors. World J Urol 29:157–163
Herpfer I, Hezel H, Reichardt W, Clark K, Geiger J, Gross CM, Heyer A, Neagu V, Bhatia H, Atas HC, Fiebich BL, Bischofberger J, Haas CA, Lieb K, Normann C (2012) Early life stress differentially modulates distinct forms of brain plasticity in young and adult mice. PLoS ONE 7:e46004
Hill AS, Sahay A, Hen R (2015) Increasing adult hippocampal neurogenesis is sufficient to reduce anxiety and depression-like behaviors. Neuropsychopharmacology 40(10):2368–2378
Howells FM, Russell VA (2008) Glutamate-stimulated release of norepinephrine in hippocampal slices of animal models of attention-deficit/hyperactivity disorder (spontaneously hypertensive rat) and depression/anxiety-like behaviours (Wistar–Kyoto rat). Brain Res 1200:107–115
Howells FM, Stein DJ, Russell VA (2012) Synergistic tonic and phasic activity of the locus coeruleus norepinephrine (LC-NE) arousal system is required for optimal attentional performance. Metab Brain Dis 27:267–274
Janthakhin Y, Rincel M, Costa AM, Darnaudery M, Ferreira G (2017) Maternal high-fat diet leads to hippocampal and amygdala dendritic remodeling in adult male offspring. Psychoneuroendocrinology 83:49–57
Jean-Charles PY, Kaur S, Shenoy SK (2017) G Protein-coupled receptor signaling through β-arrestin-dependent mechanisms. J Cardiovasc Pharmacol 70:142–158
Jin S, Zhao Y, Jiang Y, Wang Y, Li C, Zhang D, Lian B, Du Z, Sun H, Sun L (2018) Anxiety-like behaviour assessments of adolescent rats after repeated maternal separation during early life. NeuroReport 29:643–649
Johnson JG, Cohen P, Gould MS, Kasen S, Brown J, Brook JS (2002) Childhood adversities, interpersonal difficulties, and risk for suicide attempts during late adolescence and early adulthood. Arch Gen Psychiatry 59:741–749
Kessler RC, Avenevoli S, Costello EJ, Georgiades K, Green JG, Gruber MJ, He JP, Koretz D, McLaughlin KA, Petukhova M, Sampson NA, Zaslavsky AM, Merikangas KR (2012) Prevalence, persistence, and sociodemographic correlates of DSM-IV disorders in the National Comorbidity Survey Replication Adolescent Supplement. Arch Gen Psychiatry 69:372–380
Kim EJ, Pellman B, Kim JJ (2015) Stress effects on the hippocampus: a critical review. Learn Mem 22:411–416
Krasel C, Bünemann M, Lorenz K, Lohse MJ (2005) Beta-arrestin binding to the beta2-adrenergic receptor requires both receptor phosphorylation and receptor activation. J Biol Chem 280:9528–9535
Krugers HJ, Joels M (2014) Long-lasting consequences of early life stress on brain structure, emotion and cognition. Curr Top Behav Neurosci 18:81–92
Laporte SA, Miller WE, Kim KM, Caron MG (2002) beta-Arrestin/AP-2 interaction in G protein-coupled receptor internalization: identification of a beta-arrestin binging site in beta 2-adaptin. J Biol Chem 277:9247–9254
Lefkowitz RG (1998) G protein-coupled receptors. III. New roles for receptor kinases and beta-arrestins in receptor signaling and desensitization. J Biol Chem 273:18677–18680
Lefkowitz RJ, Shenoy SK (2005) Transduction of receptor signals by beta-arrestins. Science 308:512–517
Li Y, Li H, Liu X, Bao G, Tao Y, Wu Z, Xia P, Wu C, Li B, Ma L (2009) Regulation of amygdalar PKA by beta-arrestin-2/phosphodiesterase-4 complex is critical for fear conditioning. Proc Natl Acad Sci U S A 106:21918–21923
Lohse MJ, Benovic JL, Codina J, Caron MG, Lefkowitz RJ (1990) beta-Arrestin: a protein that regulates beta-adrenergic receptor function. Science 248:1547–1550
Lupien SJ, McEwen BS, Gunnar MR, Heim C (2009) Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat Rev Neurosci 10:434–445
Mc Fie S, Sterley TL, Howells FM, Russell VA (2012) Clozapine decreases exploratory activity and increases anxiety-like behaviour in the Wistar-Kyoto rat but not the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder. Brain Res 1467:91–103
Moriceau S, Shionoya K, Jakubs K, Sullivan RM (2009) Early-life stress disrupts attachment learning: the role of amygdala corticosterone, locus ceruleus corticotropin releasing hormone, and olfactory bulb norepinephrine. J Neurosci 29(50):15745–15755
Morris MJ, Dausse JP, Devynck MA, Meyer P (1980) Ontogeny of a1 and a2-adrenoceptors in rat brain. Brain Res 190:268–271
Murrin LC, Sanders JD, Bylund DB (2007) Comparison of the maturation of the adrenergic and serotonergic neurotransmitter systems in the brain: implications for differential drug effects on juveniles and adults. Biochem Pharmacol 73:1225–1236
Nalepa I, Kreiner G, Kowalska M, Sanak M, Zelek-Molik A, Vetulani J (2002) Repeated imipramine and electroconvulsive shock increase alpha 1A-adrenoceptor mRNA level in rat prefrontal cortex. Eur J Pharmacol 444:151–159
Nalepa I, Kreiner G, Bielawski A, Rafa-Zabłocka K, Roman A (2013) α1-Adrenergic receptor subtypes in the central nervous system: insights from genetically engineered mouse models. Pharmacol Rep 65:1489–1497
Oakley RH, Laporte SA, Holt JA, Caron MG, Barak LS (2000) Differential affinities of visual arrestin, beta arrestin1, and beta arrestin2 for G protein-coupled receptors delineate two major classes of receptors. J Biol Chem 275:17201–17210
Oakley RH, Laporte SA, Holt JA, Barak LS, Caron MG (2001) Molecular determinants underlying the formation of stable intracellular G protein-coupled receptor-beta-arrestin complexes after receptor endocytosis. J Biol Chem 276:19452–19460
Papay R, Gaivin R, Jha A, McCune DF, McGrath JC, Rodrigo MC, Simpson PC, Doze VA, Perez DM (2006) Localization of the mouse alpha1A-adrenergic receptor (AR) in the brain: alpha1AAR is expressed in neurons, GABAergic interneurons, and NG2 oligodendrocyte progenitors. J Comp Neurol 497(2):209–222
Pare WP (1994) Open field, learned helplessness, conditioned defensive burying, and forced-swim tests in WKY rats. Physiol Behav 55:433
Peskind ER, Bonner LT, Hoff DJ, Raskind MA (2003) Prazosin reduceds trauma-related nightmares in older men with chronic posttraumatic stress disorder. J Geriatr Psychiatry Neurol 16:165–171
Peters DA (1984) Prenatal stress: effect on development of rat brain adrenergic receptors. Pharmacol Biochem Behav 21:417–422
Philipp M, Hein L (2004) Adrenergic receptor knockout mice: distinct functions of 9 receptor subtypes. Pharmacol Ther 101(1):65–74
Piascik MT, Perez DM (2001) Alpha1-adrenergic receptors: new insights and directions. J Pharmacol Exp Ther 298(2):403–410
Pradhan AA, Perroy J, Walwyn WM, Smith ML, Vicente-Sanchez A, Segura L, Bana A, Kieffer BL, Evans CJ (2016) Agonist-specific recruitment of arrestin isoforms differentially modify delta opioid receptor function. J Neurosci 36:3541–3551
Prut L, Belzung C (2003) The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 463:3–33
Qiong W, Man L, Wei D, Feng S, Weiwen W (2015) The different effects of maternal separation on spatial learning and reversal learning in rats. Behav Brain Res 280:16–23
Raineki C, Moriceau S, Sullivan RM (2010) Developing a neurobehavioral animal model of infant attachment to an abusive caregiver. Biol Psychiatry 67:1137–1145
Rao U, Chen LA, Bidesi AS, Shad MU, Thomas MA, Hammen CL (2010) Hippocampal changes associated with early-life adversity and vulnerability to depression. Biol Psychiatry 67:357–364
Raskind MA, Peskind ER, Kanter ED, Petrie EC, Radant A, Thompson CE, Dobie DJ, Hoff D, Rein RJ, Straits-Tröster K, Thomas RG, McFall MM (2003) Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study. Am J Psychiatry 160:371–373
Rebec GV, Grabner CP, Johnson M, Pierce RC, Bardo MT (1997) Transient increases in catecholaminergic activity in medial prefrontal cortex and nucleus accumbens shell during novelty. Neuroscience 76:707–714
Rehavi M, Ramot O, Yavetz B, Sokolovsky M (1980) Amitriptyline: long-term treatment elevates alpha-adrenergic and muscarinic receptor binding in mouse brain. Brain Res 194(2):443–453
Ressler KJ, Nemeroff CB (2000) Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress Anxiety 12:2–19
Rincel M, Lépinay AL, Janthakhin Y, Soudain G, Yvon S, Da Silva S, Joffre C, Aubert A, Séré A, Layé S, Theodorou V, Ferreira G, Darnaudéry M (2018) Maternal high-fat diet and early life stress differentially modulate spine density and dendritic morphology in the medial prefrontal cortex of juvenile and adult rats. Brain Struct Funct 223:883–895
Robins MT, Chiang T, Berry JN, Ko MJ, Ha JE, van Rijn RM (2018) Behavioral characterization of β-arrestin 1 knockout mice in anxiety-like and alcohol behaviors. Front Behav Neurosci 12:54
Saitoh A, Kimura Y, Suzuki T, Kawai K, Nagase H, Kamei J (2004) Potential anxiolytic and antidepressant-like activities of SNC80, a selective delta-opioid agonist, in behavioral models in rodents. J Pharmacol Sci 95:374–380
Saitoh A, Suzuki S, Soda A, Ohashi M, Yamada M, Oka JI, Nagase H, Yamada M (2018) The delta opioid receptor agonist KNT-127 in the prelimbic medial prefrontal cortex attenuates veratrine-induced anxiety-like behaviors in mice. Behav Brain Res 336:77–84
Sanders J, Happe H, Bylund D, Murrin LC (2011) Changes in postnatal norepinephrine alter alpha-2 adrenergic receptor development. Neuroscience 192:761–772
Sara SJ, Dyon-laurent C, Herd A (1995) Novelty seeking behavior in the rat is dependent upon the integrity of the noradrenergic system. Cogn Brain Res 2:181–187
Seibenhener ML, Wooten MC (2015) Use of the open field maze to measure locomotor and anxiety-like behavior in mice. J Vis Exp 96:e52434
Sestakova N, Puzserova A, Kluknavsky M, Bernatova I (2013) Determination of motor activity and anxiety-related behaviour in rodents: methodological aspects and role of nitric oxide. Interdiscip Toxicol 6:126–135
Sevelinges Y, Moriceau S, Holman P, Miner C, Muzny K, Gervais R, Mouly AM, Sullivan RM (2007) Enduring effects of infant memories: infant odor-shock conditioning attenuates amygdala activity and adult fear conditioning. Biol Psychiatry 62:1070–1079
Sevelinges Y, Mouly MA, Moriceau S, Raineki C, Forest C, Sullivan RM (2011) Adult depression-like behavior and amygdala dysfunction rescued by odor previously paired with shock in infancy. Dev Cogn Neurosci 1:77–87
Snoddy AM, Tessel RE (1985) Prazosin: effect on psychomotor-stimulant cues and locomotor activity in mice. Eur J Pharmacol 116:221–228
Soares-Cunha C, Coimbra B, Borges S, Domingues AV, Silva D, Sousa N, Rodrigues AJ (2018) Mild prenatal stress causes emotional and brain structural modifications in rats of both sexes. Front Behav Neurosci 12:129
Stone EA, Zhang Y, Rosengarten H, Yeretsian J, Quartermain D (1999) Brain alpha 1-adrenergic neurotransmission is necessary for behavioral activation to environmental change in mice. Neuroscience 94:1245–1252
Stone EA, Yan LIN, Ahsan MR, Lehmann ML, Yeretsian J, Quartermain D (2006) Role of CNS alpha-1-adrenoceptor activity in central fos responses to novelty. Synapse 59:299–307
Stone EA, Lin Y, Sarfraz Y, Quartermain D (2011) The role of the central noradrenergic system in behavioral inhibition. Brain Res Rev 67:193–208
Sullivan GM, Coplan JD, Kent JM, Gorman JM (1999) The noradrenergic system in pathological anxiety: a focus on panic with relevance to generalized anxiety and phobias. Biol Psychiatry 46:1205–1218
Teicher MH, Andersen SL, Polcari A, Anderson CM, Navalta CP, Kim DM (2003) The neurobiological consequences of early stress and childhood maltreatment. Neurosci Biobehav Rev 27:33–44
Teicher MH, Tomoda A, Andersen SL (2006) Neurobiological consequences of early stress and childhood maltreatment: are results from human and animal studies comparable? Ann N Y Acad Sci 1071:313–323
Teicher MH, Anderson CM, Polcari A (2012) Childhood maltreatment is associated with reduced volume in the hippocampal subfields CA3, dentate gyrus, and subiculum. Proc Natl Acad Sci U S A 109:E563–E572
Tian X, Kang DS, Benovic JL (2014) β-arrestins and G protein-coupled receptor trafficking. Handb Exp Pharmacol 219:173–186
Uberti M, Hall RA, Minneman KP (2003) Subtype-specific dimerization of alpha 1adrenoceptors: effects on receptor expression and pharmacological properties. Mol Pharmacol 64:1379–1390
Vaiserman AM (2015) Epigenetic programming by early-life stress: evidence from human populations. Dev Dyn 244:254–265
van Harmelen AL, de Jong PJ, Glashouwer KA, Spinhoven P, Penninx BW, Elzinga BM (2010) Child abuse and negative explicit and automatic self-associations: the cognitive scars of emotional maltreatment. Behav Res Ther 48:486–494
van Rijn RM, Brissett DI, Whistler JL (2010) Dual efficacy of delta opioid receptor-selective ligands for ethanol drinking and anxiety. J Pharmacol Exp Ther 335:133–139
Varese F, Smeets F, Drukker M, Lieverse R, Lataster T, Viechtbauer W, Read J, van Os J, Bentall RP (2012) Childhood adversities increase the risk of psychosis: a meta-analysis of patient-control, prospective- and cross-sectional cohort studies. Schizophr Bull 38:661–671
Velley L, Kempf E, Cardo B (1982) Locomotor activity of rats after stimulation of then nucleus locus coeruleus region or after lesion of the dorsal noradrenergic bundle: effects of clonidine, prazosin and yohimbine. Psychopharmacology 78:239–244
Vicente-Sanchez A, Dripps IJ, Tipton AF, Akbari H, Akbari A, Jutkiewicz EM, Pradhan AA (2018) Tolerance to high-internalizing delta opioid receptor agonist is critically mediated by arrestin 2. Br J Pharmacol 175:3050–3059
Vindas MA, Fokos S, Pavlidis M, Höglund E, Dionysopoulou S, Ebbesson LOE, Papandroulakis N, Dermon CR (2018) Early life stress induces long-term changes in limbic areas of a teleost fish: the role of catecholamine systems in stress coping. Sci Rep 8:5638
Vythilingam M, Heim C, Newport J, Miller AH, Anderson E, Bronen R, Brummer M, Staib L, Vermetten E, Charney DS, Nemeroff CB, Bremner JD (2002) Childhood trauma associated with smaller hippocampal volume in women with major depression. Am J Psychiatry 159:2072–2080
Zohar J, Westenberg HG (2000) Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors. Acta Psychiatr Scand Suppl 403:39–49
Zurkovsky L, Sedaghat K, Ahmed MR, Gurevich VV, Gurevich EV (2017) Arrestin-2 and arrestin-3 differentially modulate locomotor responses and sensitization to amphetamine. Neuropharmacology 121:20–29
Acknowledgements
This work was supported by a grant from Neurophysiology Research Center, Cellular and Molecular Medicine Institute, Urmia University of Medical Sciences.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have declared no conflict of interest.
Additional information
Communicated by Sreedharan Sajikumar.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Mahmoodkhani, M., Amini, M., Derafshpour, L. et al. Negative relationship between brain α1A-AR neurotransmission and βArr2 levels in anxious adolescent rats subjected to early life stress. Exp Brain Res 238, 2833–2844 (2020). https://doi.org/10.1007/s00221-020-05937-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00221-020-05937-1